Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Psoas Compartment Block (PCB) Versus L.A Infiltration and Remifentanil Infusion During EVAR
Phase 2
Completed
- Conditions
- Analgesic Adverse Reaction
- Interventions
- Procedure: Psoas Compartment Block (PCB)Procedure: Local Anesthesia infiltrationDrug: Normal saline 0.9% IV infusion
- First Posted Date
- 2018-02-23
- Last Posted Date
- 2019-02-18
- Lead Sponsor
- Dr. Erfan and Bagedo General Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT03443518
- Locations
- 🇸🇦
DR Erfan hospital, Jeddah, Saudi Arabia
🇸🇦Erfan hospital, Jeddah, Saudi Arabia
News
No news found